Exelixis, Inc. (EXEL) operating KPIs
EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 17/307% above fair value
$69.39+3.19 (+4.82%)
Close on Oct 30, 2026Market cap $17.19BP/E 20.8Yield –
KPIs
Operating metrics that drive Exelixis's business
Coming soon
This tab will track the numbers specific to Exelixis's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.